These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24317453)

  • 1. The effects of venlafaxine on cortical motor area activity in healthy subjects: a pilot study.
    Li CY; Song XZ; Han LX; Xie Q; Wang J; Li YK; Liu FD; Liu Y
    J Clin Psychopharmacol; 2014 Feb; 34(1):93-8. PubMed ID: 24317453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer.
    Loubinoux I; Tombari D; Pariente J; Gerdelat-Mas A; Franceries X; Cassol E; Rascol O; Pastor J; Chollet F
    Neuroimage; 2005 Aug; 27(2):299-313. PubMed ID: 15950492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modulation of venlafaxine on cortical activation of language area in healthy subjects with fMRI study.
    Xie Q; Liu Y; Li CY; Song XZ; Wang J; Han LX; Bai HM
    Psychopharmacology (Berl); 2012 Oct; 223(4):417-25. PubMed ID: 22555622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects.
    Gerdelat-Mas A; Loubinoux I; Tombari D; Rascol O; Chollet F; Simonetta-Moreau M
    Neuroimage; 2005 Aug; 27(2):314-22. PubMed ID: 16019236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of venlafaxine on autonomic functions in healthy volunteers.
    Siepmann T; Ziemssen T; Mueck-Weymann M; Kirch W; Siepmann M
    J Clin Psychopharmacol; 2007 Dec; 27(6):687-91. PubMed ID: 18004138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
    Richard IH; McDermott MP; Kurlan R; Lyness JM; Como PG; Pearson N; Factor SA; Juncos J; Serrano Ramos C; Brodsky M; Manning C; Marsh L; Shulman L; Fernandez HH; Black KJ; Panisset M; Christine CW; Jiang W; Singer C; Horn S; Pfeiffer R; Rottenberg D; Slevin J; Elmer L; Press D; Hyson HC; McDonald W;
    Neurology; 2012 Apr; 78(16):1229-36. PubMed ID: 22496199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man.
    Bitsios P; Szabadi E; Bradshaw CM
    Psychopharmacology (Berl); 1999 Apr; 143(3):286-92. PubMed ID: 10353432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic enhancement improves motor network connectivity in stroke patients.
    Wang LE; Fink GR; Diekhoff S; Rehme AK; Eickhoff SB; Grefkes C
    Ann Neurol; 2011 Feb; 69(2):375-88. PubMed ID: 21387380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional MRI study of motor dysfunction in Friedreich's ataxia.
    Akhlaghi H; Corben L; Georgiou-Karistianis N; Bradshaw J; Delatycki MB; Storey E; Egan GF
    Brain Res; 2012 Aug; 1471():138-54. PubMed ID: 22771856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.
    Chial HJ; Camilleri M; Ferber I; Delgado-Aros S; Burton D; McKinzie S; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2003 May; 1(3):211-8. PubMed ID: 15017493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers.
    Siepmann T; Mueck-Weymann M; Oertel R; Kirch W; Pittrow D; Siepmann M
    Pharmacopsychiatry; 2008 Jul; 41(4):146-50. PubMed ID: 18651343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The positive effect of venlafaxine on central motor conduction.
    Li C; Liu F; Peng H; Huang Y; Song X; Xie Q; Li Y; Liu Y
    Clin Neurol Neurosurg; 2018 Apr; 167():65-69. PubMed ID: 29454182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of the dual mechanisms of action of venlafaxine.
    Harvey AT; Rudolph RL; Preskorn SH
    Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
    Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1999 Sep; 48(3):345-54. PubMed ID: 10510145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
    Lu L; Su WJ; Yue W; Ge X; Su F; Pei G; Ma L
    Life Sci; 2001 May; 69(1):37-46. PubMed ID: 11411809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of unilateral and bilateral complex finger tapping-related activation in premotor and primary motor cortex.
    Horenstein C; Lowe MJ; Koenig KA; Phillips MD
    Hum Brain Mapp; 2009 Apr; 30(4):1397-412. PubMed ID: 18537112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states.
    Homero de Souza Filho J; Bonifácio FN; Bedor DC; Ramos VL; de Sousa CE; Sardón LL; Gonçalves TM; Moreira RC; Leal LB; de Santana DP
    Clin Ther; 2010 Nov; 32(12):2088-96. PubMed ID: 21118744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.